![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 7, 4561-4564, February 18, 2000
,
,
,
,
¶
From the
Institute of Cytology RAS, 4 Tikhoretsky
Ave., St. Petersburg 194064, Russia and the § Department
of Physiology, University of Texas Southwestern Medical Center,
Dallas, Texas 75235
| |
ABSTRACT |
|---|
|
|
|---|
In most nonexcitable cells, calcium
(Ca2+) release from inositol 1,4,5-trisphosphate
(InsP3)-sensitive intracellular Ca2+ stores is
coupled to Ca2+ influx (calcium release-activated
channels (ICRAC)) pathway. Despite
intense investigation, the molecular identity of
ICRAC and the mechanism of its activation
remain poorly understood. InsP3-dependent
miniature calcium channels (Imin) display
functional properties characteristic for ICRAC.
Here we used patch clamp recordings of Imin
channels in human carcinoma A431 cells to demonstrate that
Imin activity was greatly enchanced in the
presence of anti-phosphatidylinositol 4,5-bisphosphate antibody
(PIP2Ab) and diminished in the presence of
PIP2. Anti-PIP2 antibody induced a greater than
6-fold increase in Imin sensitivity for
InsP3 activation and an almost 4-fold change in
Imin maximal open probability. The addition of
exogenous PIP2 vesicles to the cytosolic surface of
inside-out patches inhibited Imin activity.
These results lead us to propose an existence of a Ca2+
influx pathway in nonexcitable cells activated via direct
conformational coupling with a selected population of InsP3
receptors, located just underneath the plasma membrane and coupled to
PIP2. The described pathway provides for a highly
compartmentalized Ca2+ influx and intracellular
Ca2+ store refilling mechanism.
Stimulation of nonexcitable cells by agonists acting via the
phospholipase C-mediated signaling pathway causes the depletion of
InsP31-sensitive
intracellular Ca2+ stores and activation of
Ca2+ influx across the plasma membrane, the process known
as capacitative Ca2+ entry (1-3). Capacitative
Ca2+ entry is mediated by plasma membrane Ca2+
channels termed "Ca2+ release activated channels"
(ICRAC) (4, 5). Despite intense investigation,
the molecular identity of ICRAC remain unclear (1-3). In experiments with the human carcinoma A431 cell line, we have
previously described miniature Ca2+ channels
(Imin), which are activated by application of
uridine trisphosphate and bradykinin to cell-attached patches or by
application of InsP3 to excised inside-out patches (6-8).
Channels that share some common properties with
Imin have also been observed in experiments with
human T-cells (9) and rat macrophages (8) and in endothelial cells (10,
11). Major functional properties of Imin
channels, such as small conductance (1 picosiemens for divalent
cations), high selectivity for divalent cations
(PCa/K > 1,000), inward rectification, and
sensitivity to block by SKF95365 are very similar to properties of
ICRAC channels (8, 12).
Imin activity is induced in cell-attached
patches by the addition of thapsigargin to the pipette
solution,2 further supporting
the notion that Imin and
ICRAC are in fact the same channel.
The mechanism of ICRAC activation remains
similarly controversial (1-3), with attention in the field primarily
focused on two major hypotheses. In the first scenario,
ICRAC is activated by a "diffusible
messenger" released by depleted Ca2+ stores (13). In the
second scenario, ICRAC is activated via a direct
mechanical connection with the intracellular InsP3R via a
"conformational coupling" mechanism (1, 14). Evidence for a
"conformational coupling" model comes from the highly
compartmentalized connection between InsP3-induced
Ca2+ release and Ca2+ influx processes
(15-19). Direct InsP3R-ICRAC
conformational coupling has been experimentally supported by recent
data obtained with recombinantly expressed mammalian trp
channels (20-22) and with Imin in human
carcinoma A431 cells (12).
InsP3R located just underneath the plasma membrane must
exist in cells to support formation of
InsP3R-Imin complexes. It has been
recently proposed that a subpopulation of intracellular
InsP3R forms tight complexes with phosphatidylinositol
4,5-bisphosphate (PIP2) in the plasma membrane (23). Can
the same InsP3R interact with both Imin and
PIP2? Can the
Imin-InsP3R-PIP2 complex
mediate signal transduction? To answer these questions, here we tested the effects of monoclonal anti-PIP2 antibody
(PIP2Ab) (24) and exogenous PIP2 on
Imin activity in patches excised from A431
cells. We found that PIP2Ab activated and exogenous
PIP2 inhibited Imin activity. Based
on these results, we propose a novel
Imin-InsP3R-PIP2 functional coupling model.
Electrophysiological Recordings--
Human carcinoma A431 cells
(Cell Culture Collection, Institute of Cytology, St. Petersburg,
Russia) were kept in culture as described elsewhere (8). For patch
clamp experiments, cells were seeded onto coverslips and maintained in
culture for 1-3 days before use. Single-channel currents were recorded
using the inside-out configuration of the patch clamp technique (25). Currents filtered at 500 Hz were recorded using a PC-501A patch clamp
amplifier (Warner Instruments, USA) with a conventional feedback
resistance in the head stage (10 gigaohms). During recording, the
currents were digitized at 2.5 kHz. For data analysis and presentation,
currents were additionally digitally filtered as indicated.
Imin open probability (NPo) was
determined using the following equation: NPo = <I>/i where <I> and i
are the mean channel current and unitary current amplitude,
respectively. <I> was estimated from the time integral of
the current above the base line, and i was determined from
current records and all-point amplitude histograms. Data were collected
from 20-s current records after channel activity reached steady state.
Unless otherwise specified, all experiments were performed at standard
conditions optimal for ICa activity at Materials--
PIP2Ab (24) was from PerSeptive
Biosystems. PIP2Ab was reconstituted in phosphate-buffered
saline (titer 1:1500), diluted 1:100 by intracellular solution, and
used for chamber perfusion. Stearoyl-arachidonyl 4,5-PIP2
was from Roche Molecular Biochemicals. PIP2 vesicles were
prepared as described previously (23) and applied to the patch at the
10 µM final concentration by rapid bath perfusion.
4-4-bromophenacylbromide and HEPES were from Sigma; EGTA was from
Fluka Chemie AG (Buchs, Switzerland). InsP3 and U73122 were
from Calbiochem.
Anti-PIP2 Antibody Activates Imin--
In
inside-out patches excised from the plasma membrane of human carcinoma
A431 cells, the application of 5 µM InsP3 to
the cytoplasmic side of the patch in approximately 50% of experiments induced activation of Imin (Fig.
1A). At 5 µM
InsP3, Imin activity in excised patches was
transient due to InsP3-dependent inactivation (8), and channel activity rapidly subsided (Fig. 1, A and
B). We found that Imin activity can
be restored and further enchanced by the application of
PIP2Ab (24) to the cytosolic side of the patch membrane
(Fig. 1, A and B). PIP2Ab activated
Imin in all experiments (11 of 11), and, on average,
increased channel NPo in the presence of 2.5 µM InsP3 from 0.8 ± 0.2 (n = 13) to 3.0 ± 0.2 (n = 7).
The addition of boiled PIP2Ab had no effect on Imin (n = 5). By reversing the
order of InsP3 and PIP2Ab additions to the
patch, we established that InsP3 was absolutely required to
register channel activity (Fig. 1C). Moreover,
current-voltage relationship and voltage-dependence of channels
observed in the presence of PIP2Ab and InsP3
were indistinguishable from the corresponding properties of
Imin channels recorded in the presence of
InsP3 alone (Fig. 1, D and E).
Anti-PIP2 Antibody Increases Sensitivity of
Imin to InsP3 Activation--
To gain
insight into the mechanism of PIP2Ab action, we
characterized the effect of PIP2Ab on
Imin sensitivity to activation by
InsP3. In this series of experiments, we determined the
mean NPo of Imin in
inside-out patches as a function of InsP3 concentration. Fit to the data obtained in control conditions (Fig.
2, filled circles)
yielded apparent affinity (Kapp) of 0.51 µM InsP3, maximal NPo
(NPomax) of 0.87 and a Hill
coefficient (nH) of 1.05 (curve). In
contrast, fit to the data obtained in the presence of
PIP2Ab (Fig. 2, open circles)
resulted in Kapp of 0.08 µM
InsP3, NPomax of
3.21, and nH of 0.8 (curve). Thus, on
average, PIP2Ab induced a greater than 6-fold change in
Imin apparent affinity for InsP3 and
a 3.7-fold change in NPomax.
PIP2Ab did not activate Imin in the
absence of InsP3 (Fig. 1C) but instead
dramatically increased the potency of InsP3 to activate Imin (Fig. 2).
PIP2 Inhibits Imin--
PIP2Ab
acts by specifically chelating PIP2 (24). The
addition of exogenous PIP2 is expected to have an effect
opposite to that of PIP2Ab. Indeed, the addition of
PIP2 vesicles to the cytosolic surface of inside-out
patches inhibited InsP3-activated
Imin (Fig. 3A) (15 of 18) and shifted
InsP3 dose-dependence curve toward lower apparent affinity
for InsP3 (Fig. 2, triangles). The inhibitory influence of PIP2 could be partially overcome by raising
InsP3 concentration to 20 µM (Figs. 2 and
3A). The addition of high InsP3 concentrations
prior to PIP2 was not possible due to
InsP3-induced desensitization of
Imin (8). An ability of PIP2 to
inhibit Imin was not significantly affected by
phospholipase A2 inhibitor 4-bromophenacylbromide (Fig.
3B) (9 of 13) or phospholipase C inhibitor U73122 (Fig.
3C) (4 of 4). Thus, it is unlikely that exogenous
PIP2 needs to be converted to arachidonic acid (8) or
diacylglycerol to inhibit Imin. Moreover, diacylglycerol
had no inhibitory effect on Imin activity (6 of
6) (data not shown).
Imin-InsP3R-PIP2 Coupling
Model--
Activation of Imin by
PIP2Ab in inside-out patches (Fig. 1), a dramatic shift in
Imin InsP3 dose dependence induced
by PIP2Ab (Fig. 2), and the ability of PIP2 to
exert the opposite effects (Fig. 3) are all highly reminiscent of
recently described effects of PIP2Ab and PIP2
on intracellular InsP3R (23). We recently demonstrated
direct Imin-InsP3R functional
coupling (12). The data described in the present report can be
explained under the assumption that the Imin in
A431 cells are directly coupled to InsP3R-PIP2
complexes proposed to exist underneath the plasma membrane (Fig.
4A). It is generally believed
that inside-out patch is not a bare bilayer but rather a
membrane-covered bleb of cytoplasm (26) that may include
InsP3R-containing organelles and cytoskeleton. We reason
that PIP2Ab and PIP2 exert an influence on
InsP3R as described previously (23); change in
InsP3R conformation is in turn transmitted to changes in
Imin behavior via the conformation coupling
mechanism (1, 12, 14, 20, 21). PIP2 binds to the
amino-terminal ligand binding domain of the InsP3R
(InsP3R-N) (23),3
the same region that has been implicated in regulation of recombinant human trp3 activity (21).
Cleavage of InsP3R-tethered PIP2 has been
previously proposed to lead to localized Ca2+ release from
the "trigger" stores and Ca2+ wave initiation (23).
"On-site" conversion of PIP2 into InsP3 should induce large scale conformational changes of the
InsP3R-N domain (27). Conformational change of the
InsP3R-N domain, which plays an organizing role in
Imin-InsP3R-PIP2 complex
formation, leads to opening of the InsP3R channel gate and
to activation of Imin via direct protein-protein
interaction (Fig. 4B). Indeed, only
InsP3-ligated InsP3R-N is able to evoke human
trp3 channel activity (21), in general agreement with our
model. The proposed model also agrees with much of experimental
evidence supporting a highly compartmentalized connection between
InsP3-induced Ca2+ release and Ca2+
influx (15-18).
The proposed coupling model (Fig. 4) implies that InsP3R is
essential for capacitative Ca2+ entry channel activation.
The removal of all three InsP3R isoforms by genetic means
in chicken B lymphocytes had no effect on thapsigargin-induced Ca2+ influx (28), apparently in direct conflict with the
conformational coupling model. The existence of at least one more
Ca2+ influx pathway in nonexcitable cells can potentially
account for these results. This additional pathway may be stimulated by the global intracellular Ca2+ store depletion and does not
require InsP3R for activation. Additional studies are
needed to clarify which channel type is responsible for an
InsP3R-independent Ca2+ influx in nonexcitable cells.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
70 mV
holding potential. The pipette solution contained 105 mM
BaCl2 and 10 mM Tris/HCl (pH 7.4). The standard intracellular solution contained 140 mM potassium
glutamate, 5 mM NaCl, 1 mM MgCl2,
10 mM HEPES/KOH, 1.13 mM CaCl2, and
2 mM EGTA (pCa 7, pH 7.4). Experiments were carried out at
room temperature (22-24 °C).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (25K):
[in a new window]
Fig. 1.
PIP2Ab enchances
Imin activity. A, current
traces in inside-out patches recorded in control, after application of
InsP3 and PIP2Ab at
70 mV holding potential.
The fragments of current records are shown at the bottom on
an expanded time scale. The unitary current amplitude of
Imin in utilized recording conditions is 0.18 pA. Filtering is 100 Hz. B, Imin
NPo plot for the experiment shown in
A. NPo was averaged over 0.5-s
intervals and plotted versus time in the experiment. Mean
NPo was 0.71 after InsP3 application
and 3.31 after PIP2Ab addition. Data are representative for
11 experiments. C, activation of Imin by InsP3
in the presence of PIP2Ab. Current traces were recorded at
a compressed time scale (top) and an expanded time scale
(bottom). D and E, current-voltage
relationship and NPo voltage dependence of
Imin channels are unaffected by
PIP2Ab antibodies. Open circles,
InsP3 alone; filled triangles,
InsP3 plus PIP2Ab. Average data are shown as
mean ± S.E. (n
6). NPo
values were normalized to the value obtained at
70 mV in the same
experiment.

View larger version (16K):
[in a new window]
Fig. 2.
PIP2Ab increases the apparent
affinity of Imin for
InsP3. Filled circles,
InsP3 alone; open circles,
InsP3 plus PIP2Ab. Average data at each
InsP3 concentration are shown as mean ± S.E., with
the number of experiments used to generate each data point as
indicated. Both sets of data were fit with the equation
NPo = NPomax
[InsP3]nH/([InsP3]nH + KappnH). The values
of parameters resulting in the best fit (smooth
curves) are given under "Results." The estimate of the
curve position in the presence of InsP3 plus
PIP2 (filled triangles) is shown by a
dotted line.

View larger version (18K):
[in a new window]
Fig. 3.
Exogenous PIP2 inhibits the
activity of Imin. A, 10 µM PIP2 inhibits activity of
Imin channels activated by 2.5 µM
InsP3. The data are shown as an NPo
versus time plot. A similar effect was observed in 15 of 18 experiments. The addition of 20 µM InsP3
partially restored channel activity following PIP2
inhibition. B and C, pretreatment of cells with 1 µM 4-bromophenacylbromide (4-BPB) (9 of 13) or
10 µM U73122 (4 of 4) and their presence in the internal
solution does not prevent PIP2 inhibition of
Imin.

View larger version (56K):
[in a new window]
Fig. 4.
Model of Imin
functional coupling to InsP3R-PIP2
complex. A, in the resting state, a population of
InsP3R localized underneath the plasma membrane forms a
tight inhibitory complex with PIP2 in the juxtaposed
membrane (23). We propose that the same InsP3Rs are
directly or indirectly coupled to Imin
Ca2+ influx channels in the plasma membrane. B,
hormonal stimulation leads to activation of PLC, cleavage of
InsP3R-tethered PIP2, generation of
InsP3 "on site," and the conformational change of the
InsP3R (23). We propose that the induced conformational
change of the InsP3R is coupled to the opening of
Imin channels, activation of localized
Ca2+ influx across the plasma membrane, and
compartmentalized Ca2+ store refilling process.
| |
FOOTNOTES |
|---|
* This work was supported by a grant from the Russian Basic Research Foundation (to G. N. M) and by National Institutes of Health Grant NS38082 (to I. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 812-247-1497; Fax: 812-247-0341; E-mail: gnmozh@link.cytspb.rssi.ru.
2 E. Kaznacheyeva, A. Zubov, A. Nikolaev, V. Alexeenko, I. Bezprozvanny, and G. N. Mozhayeva, unpublished results.
3 L. Glouchankova and I. Bezprozvanny, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: InsP3, inositol 1,4,5-trisphosphate; ICRAC, calcium release-activated channel(s); Imin, InsP3-dependent miniature calcium channel(s); InsP3R, InsP3 receptor; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP2Ab, anti-PIP2 monoclonal antibody.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berridge, M. J. (1995) Biochem. J. 312, 1-11 |
| 2. |
Parekh, A. B.,
and Penner, R.
(1997)
Physiol. Rev.
77,
901-930 |
| 3. | Putney, J. W., Jr., and McKay, R. R. (1999) BioEssays 21, 38-46[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Kerschbaum, H. H.,
and Cahalan, M. D.
(1999)
Science
283,
836-839 |
| 5. | Hoth, M., and Penner, R. (1992) Nature 355, 353-356[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Mozhayeva, G. N., Naumov, A. P., and Kuryshev, Y. A. (1990) FEBS Lett. 277, 233-234[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Kiselyov, K. I., Mamin, A. G., Semyonova, S. B., and Mozhayeva, G. N. (1997) FEBS Lett. 407, 309-312[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Kiselyov, K. I., Semyonova, S. B., Mamin, A. G., and Mozhayeva, G. N. (1999) Pflugers Arch. 437, 305-314[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Kuno, M., and Gardner, P. (1987) Nature 326, 301-304[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Luckhoff, A., and Clapham, D. E. (1992) Nature 355, 356-358[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Vaca, L.,
and Kunze, D. L.
(1995)
Am. J. Physiol.
269,
C733-C738 |
| 12. |
Zubov, A. I.,
Kaznacheyeva, E. V.,
Nikolaev, A. V.,
Alexeenko, V. A.,
Kiselyov, K.,
Muallem, S.,
and Mozhayeva, G. N.
(1999)
J. Biol. Chem.
274,
25983-25985 |
| 13. | Putney, J. W., Jr., and Bird, G. S. (1993) Cell 75, 199-201[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Irvine, R. F. (1990) FEBS Lett. 263, 5-9[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Paradiso, A. M., Mason, S. J., Lazarowski, E. R., and Boucher, R. C. (1995) Nature 377, 643-646[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Petersen, C. C., and Berridge, M. J. (1996) Pflugers Arch. 432, 286-292[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Parekh, A. B., Fleig, A., and Penner, R. (1997) Cell 89, 973-980[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Gregory, R. B., Wilcox, R. A., Berven, L. A., Van Straten, N. C., Van Der Marel, G. A., Van Boom, J. H., and Barritt, G. J. (1999) Biochem. J. 341, 401-408 |
| 19. |
Huser, J.,
Holda, J. R.,
Kockskamper, J.,
and Blatter, L. A.
(1999)
J. Physiol. (Lond.)
514,
101-109 |
| 20. | Kiselyov, K., Xu, X., Mozhayeva, G., Kuo, T., Pessah, I., Mignery, G., Zhu, X., Birnbaumer, L., and Muallem, S. (1998) Nature 396, 478-482[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kiselyov, K., Mignery, G. A., Zhu, M. X., and Muallem, S. (1999) Mol. Cell 4, 423-429[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Vannier, B.,
Peyton, M.,
Boulay, G.,
Brown, D.,
Qin, N.,
Jiang, M.,
Zhu, X.,
and Birnbaumer, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2060-2064 |
| 23. |
Lupu, V. D.,
Kaznacheyeva, E.,
Krishna, U. M.,
Falck, J. R.,
and Bezprozvanny, I.
(1998)
J. Biol. Chem.
273,
14067-14070 |
| 24. |
Fukami, K.,
Matsuoka, K.,
Nakanishi, O.,
Yamakawa, A.,
Kawai, S.,
and Takenawa, T.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
9057-9061 |
| 25. | Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981) Pfluegers Arch. 391, 85-100[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Ruknudin, A.,
Song, M. J.,
and Sachs, F.
(1991)
J. Cell Biol.
112,
125-134 |
| 27. | Mignery, G. A., and Sudhof, T. C. (1990) EMBO J. 9, 3893-3898[Medline] [Order article via Infotrieve] |
| 28. | Sugawara, H., Kurosaki, M., Takata, M., and Kurosaki, T. (1997) EMBO J. 16, 3078-3088[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
E. Kaznacheyeva, L. Glushankova, V. Bugaj, O. Zimina, A. Skopin, V. Alexeenko, L. Tsiokas, I. Bezprozvanny, and G. N. Mozhayeva Suppression of TRPC3 Leads to Disappearance of Store-operated Channels and Formation of a New Type of Store-independent Channels in A431 Cells J. Biol. Chem., August 10, 2007; 282(32): 23655 - 23662. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. del Pilar Gomez and E. Nasi A Direct Signaling Role for Phosphatidylinositol 4,5-Bisphosphate (PIP2) in the Visual Excitation Process of Microvillar Receptors J. Biol. Chem., April 29, 2005; 280(17): 16784 - 16789. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bugaj, V. Alexeenko, A. Zubov, L. Glushankova, A. Nikolaev, Z. Wang, E. Kaznacheyeva, I. Bezprozvanny, and G. N. Mozhayeva Functional Properties of Endogenous Receptor- and Store-operated Calcium Influx Channels in HEK293 Cells J. Biol. Chem., April 29, 2005; 280(17): 16790 - 16797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Parekh and J. W. Putney Jr. Store-Operated Calcium Channels Physiol Rev, April 1, 2005; 85(2): 757 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ma, D. Rundle, J. Jacks, M. Koch, T. Downs, and L. Tsiokas Inhibitor of Myogenic Family, a Novel Suppressor of Store-operated Currents through an Interaction with TRPC1 J. Biol. Chem., December 26, 2003; 278(52): 52763 - 52772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gusev, L. Glouchankova, A. Zubov, E. Kaznacheyeva, Z. Wang, I. Bezprozvanny, and G. N. Mozhayeva The Store-operated Calcium Entry Pathways in Human Carcinoma A431 Cells: Functional Properties and Activation Mechanisms J. Gen. Physiol., June 30, 2003; 122(1): 81 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Baluska, M. von Witsch, M. Peters, A. Hlavacka, and D. Volkmann Mastoparan Alters Subcellular Distribution of Profilin and Remodels F-Actin Cytoskeleton in Cells of Maize Root Apices Plant Cell Physiol., September 1, 2001; 42(9): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukami, K. Nakao, T. Inoue, Y. Kataoka, M. Kurokawa, R. A. Fissore, K. Nakamura, M. Katsuki, K. Mikoshiba, N. Yoshida, et al. Requirement of Phospholipase Cdelta 4 for the Zona Pellucida-Induced Acrosome Reaction Science, May 4, 2001; 292(5518): 920 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kaznacheyeva, A. Zubov, K. Gusev, I. Bezprozvanny, and G. N. Mozhayeva Activation of calcium entry in human carcinoma A431 cells by store depletion and phospholipase C- dependent mechanisms converge on ICRAC-like calcium channels PNAS, January 2, 2001; 98(1): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu and I. S. Ambudkar Characteristics of a Store-operated Calcium-permeable Channel. SARCOENDOPLASMIC RETICULUM CALCIUM PUMP FUNCTION CONTROLS CHANNEL GATING J. Biol. Chem., August 3, 2001; 276(32): 29891 - 29898. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |